Are you Dr. Burnett?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
417 Main St
Chatham, NJ 07928Phone+1 973-635-5050
Summary
- Dr. Patrick Burnett, MD is a dermatologist in Chatham, New Jersey. He is currently licensed to practice medicine in New Jersey, Tennessee, and New York.
Education & Training
NYU Grossman School of MedicineResidency, Dermatology, 2001 - 2004
Johns Hopkins UniversityInternship, Internal Medicine, 2000 - 2001- Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
NY State Medical License 2003 - 2026
NJ State Medical License 2023 - 2025
TN State Medical License 2004 - 2011
Publications & Presentations
PubMed
- 4 citationsSafety and Efficacy of VP-102 (Cantharidin, 0.7% w/v) in Molluscum Contagiosum by Body Region:Pooled Analyses from Two Phase III Randomized Trials.Lawrence F Eichenfield, Pearl Kwong, Mercedes E Gonzalez, Albert Yan, Pieter D'Arnaud
The Journal of Clinical and Aesthetic Dermatology. 2021-10-01 - 26 citationsBiological challenges of BRAF inhibitor therapy.Igor Puzanov, Patrick E. Burnett, Keith T. Flaherty
Molecular Oncology. 2011-04-01 - 108 citationsp120-catenin is essential for maintenance of barrier function and intestinal homeostasis in miceWhitney G. Smalley-Freed, Andrey Efimov, Patrick E. Burnett, Sarah P. Short, Michael Davis
The Journal of Clinical Investigation. 2010-06-01
Press Mentions
Arcutis Presents Late-Breaking Data from the INTEGUMENT Phase 3 Trials in Atopic Dermatitis at American Academy of Dermatology Annual MeetingMarch 18th, 2023- Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque PsoriasisJanuary 14th, 2023
- Study Showing Significant Improvements in Itch and Itch-Related Sleep Loss with Roflumilast Cream in Adults with Plaque Psoriasis Published in American Journal of Clinical DermatologyNovember 28th, 2022
- Join now to see all
